Advertisement
UK markets close in 6 hours 40 minutes
  • FTSE 100

    8,091.42
    +51.04 (+0.63%)
     
  • FTSE 250

    19,710.43
    -8.94 (-0.05%)
     
  • AIM

    754.95
    +0.26 (+0.03%)
     
  • GBP/EUR

    1.1672
    +0.0027 (+0.24%)
     
  • GBP/USD

    1.2523
    +0.0060 (+0.48%)
     
  • Bitcoin GBP

    50,932.35
    -2,277.37 (-4.28%)
     
  • CMC Crypto 200

    1,360.93
    -21.64 (-1.56%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.15
    +0.34 (+0.41%)
     
  • GOLD FUTURES

    2,339.80
    +1.40 (+0.06%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,994.78
    -93.92 (-0.52%)
     
  • CAC 40

    8,063.95
    -27.91 (-0.34%)
     

Cronos Group (CRON) Catches Eye: Stock Jumps 9.3%

Cronos Group Inc. CRON was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 37.6% in the past one-month time frame.

The company has seen one negative estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Cronos Group currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Cronos Group Inc. Price

Cronos Group Inc. Price
Cronos Group Inc. Price

Cronos Group Inc. price | Cronos Group Inc. Quote

ADVERTISEMENT

A better-ranked stock in the Medical - Drugs industry is Bellicum Pharmaceuticals, Inc. BLCM, which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2021.

Click here for the 6 trades >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Bellicum Pharmaceuticals, Inc. (BLCM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research